Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma.
Fibroblast growth factor receptor 4 (FGFR4) polymorphisms are positively correlated with tumor progression in numerous malignant tumors. However, the association between FGFR4 genetic variants and the risk of hepatocellular carcinoma (HCC) has not yet been determined. In this study, we investigated...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4393280?pdf=render |
| _version_ | 1828727033275875328 |
|---|---|
| author | Ming-Jen Sheu Ming-Ju Hsieh Whei-Ling Chiang Shun-Fa Yang Hsiang-Lin Lee Liang-Ming Lee Chao-Bin Yeh |
| author_facet | Ming-Jen Sheu Ming-Ju Hsieh Whei-Ling Chiang Shun-Fa Yang Hsiang-Lin Lee Liang-Ming Lee Chao-Bin Yeh |
| author_sort | Ming-Jen Sheu |
| collection | DOAJ |
| description | Fibroblast growth factor receptor 4 (FGFR4) polymorphisms are positively correlated with tumor progression in numerous malignant tumors. However, the association between FGFR4 genetic variants and the risk of hepatocellular carcinoma (HCC) has not yet been determined. In this study, we investigated the potential associations of FGFR4 single nucleotide polymorphisms (SNPs) with HCC susceptibility and its clinicopathological characteristics.Four SNPs in FGFR4 (rs1966265, rs351855, rs2011077, and rs7708357) were analyzed among 884 participants, including 595 controls and 289 patients with HCC. The samples were further analyzed to clarify the associations between these gene polymorphisms and the risk of HCC, and the impact of these SNPs on the susceptibility and clinicopathological characteristics of HCC. After adjusting for other covariants, HCC patients who carrying at least one A genotype (GA and AA) at rs351855 were observed to have a higher risk of liver cirrhosis compared with those carrying the wild-type genotype (GG) (OR: 2.113, 95% CI: 1.188-3.831). Moreover, the patients with at least one A genotype were particularly showed a high level of alpha-fetoprotein (AFP).Our findings suggest that genetic polymorphism in FGFR4 rs351855 may be associated with the risk of HCC coupled with liver cirrhosis and may markedly increase the AFP level in Taiwanese patients with HCC. In addition, this is the first study that evaluated the risk factors associated with FGFR4 polymorphism variants in Taiwanese patients with HCC. |
| first_indexed | 2024-04-12T13:51:53Z |
| format | Article |
| id | doaj.art-25bea2df7745498b9c89c847c82c19f8 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-12T13:51:53Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-25bea2df7745498b9c89c847c82c19f82022-12-22T03:30:30ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012296110.1371/journal.pone.0122961Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma.Ming-Jen SheuMing-Ju HsiehWhei-Ling ChiangShun-Fa YangHsiang-Lin LeeLiang-Ming LeeChao-Bin YehFibroblast growth factor receptor 4 (FGFR4) polymorphisms are positively correlated with tumor progression in numerous malignant tumors. However, the association between FGFR4 genetic variants and the risk of hepatocellular carcinoma (HCC) has not yet been determined. In this study, we investigated the potential associations of FGFR4 single nucleotide polymorphisms (SNPs) with HCC susceptibility and its clinicopathological characteristics.Four SNPs in FGFR4 (rs1966265, rs351855, rs2011077, and rs7708357) were analyzed among 884 participants, including 595 controls and 289 patients with HCC. The samples were further analyzed to clarify the associations between these gene polymorphisms and the risk of HCC, and the impact of these SNPs on the susceptibility and clinicopathological characteristics of HCC. After adjusting for other covariants, HCC patients who carrying at least one A genotype (GA and AA) at rs351855 were observed to have a higher risk of liver cirrhosis compared with those carrying the wild-type genotype (GG) (OR: 2.113, 95% CI: 1.188-3.831). Moreover, the patients with at least one A genotype were particularly showed a high level of alpha-fetoprotein (AFP).Our findings suggest that genetic polymorphism in FGFR4 rs351855 may be associated with the risk of HCC coupled with liver cirrhosis and may markedly increase the AFP level in Taiwanese patients with HCC. In addition, this is the first study that evaluated the risk factors associated with FGFR4 polymorphism variants in Taiwanese patients with HCC.http://europepmc.org/articles/PMC4393280?pdf=render |
| spellingShingle | Ming-Jen Sheu Ming-Ju Hsieh Whei-Ling Chiang Shun-Fa Yang Hsiang-Lin Lee Liang-Ming Lee Chao-Bin Yeh Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma. PLoS ONE |
| title | Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma. |
| title_full | Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma. |
| title_fullStr | Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma. |
| title_full_unstemmed | Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma. |
| title_short | Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma. |
| title_sort | fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma |
| url | http://europepmc.org/articles/PMC4393280?pdf=render |
| work_keys_str_mv | AT mingjensheu fibroblastgrowthfactorreceptor4polymorphismisassociatedwithlivercirrhosisinhepatocarcinoma AT mingjuhsieh fibroblastgrowthfactorreceptor4polymorphismisassociatedwithlivercirrhosisinhepatocarcinoma AT wheilingchiang fibroblastgrowthfactorreceptor4polymorphismisassociatedwithlivercirrhosisinhepatocarcinoma AT shunfayang fibroblastgrowthfactorreceptor4polymorphismisassociatedwithlivercirrhosisinhepatocarcinoma AT hsianglinlee fibroblastgrowthfactorreceptor4polymorphismisassociatedwithlivercirrhosisinhepatocarcinoma AT liangminglee fibroblastgrowthfactorreceptor4polymorphismisassociatedwithlivercirrhosisinhepatocarcinoma AT chaobinyeh fibroblastgrowthfactorreceptor4polymorphismisassociatedwithlivercirrhosisinhepatocarcinoma |